Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label study to assess the efficacy, safety and tolerability of Cozaar plus (losartan potassium 50mg/hydrochlorothiazide 12.5mg) possibly titrated up to Cozaar plus-F (losartan potassium 100mg/hydrochlorothiazide 25mg) in patients with essential hypertension

Next Previous
Trial Profile

An open label study to assess the efficacy, safety and tolerability of Cozaar plus (losartan potassium 50mg/hydrochlorothiazide 12.5mg) possibly titrated up to Cozaar plus-F (losartan potassium 100mg/hydrochlorothiazide 25mg) in patients with essential hypertension

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Organon

    • Most Recent Events

    • 18 May 2007 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top